The findings from both in vitro and in vivo studies highlight the potential of pericytes as a therapeutic target for seizure disorders, as indicated by the efficacy of PDGF-BB and imatinib in blocking PDGFRβ. This evidence concerns the gene PDGFRB and epilepsy.